Skip to content

Return on equity at other companies

Abbott logo
AbbottABT
12.4%-18.4pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
4.6%-1.3pp
TFX
TeleflexTFX
-28.1%-31.6pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
26.4%-3.0pp
Boston Scientific logo
Boston ScientificBSX
14.8%+5.2pp
Edwards Lifesciences logo
Edwards LifesciencesEW
10.7%-37.8pp

Other financials

Income statement

See full
Revenue$381.9M+7.5%
Gross profit$184.8M+7.4%
Operating income$44.2M+7.6%
Net income$41.0M+36.0%
EPS (diluted)$0.68+38.8%

Balance sheet

See full
Cash & equivalents$488.1M+23.4%
Total debt$821.6M+0.5%
Total equity$1.6B+13.9%
Total assets$2.7B+10.2%

Cash flow

See full
Operating cash flow$40.7M+0.3%
CapEx$16.0M-24.0%
Free cash flow$24.7M+26.5%

Valuation

See full
Market cap$4.01B-34.1%
Enterprise value$4.34B-33.3%
P/E28.8×-21.0×
P/S2.6×-1.8×

Profitability

See full
Gross margin48.7%+0.9pp
Operating margin12.2%+0.6pp
Net margin9%+0.2pp
FCF margin14.3%+1.3pp

Returns & leverage

See full
Debt / equity0.5×-0.1×
Current ratio5.1×+0.2×

Where this comes from

Calculated from Merit Medical Systems’s reported figures.

Based on trailing twelve months.

The official record: Merit Medical Systems’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Merit Medical Systems's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Merit Medical Systems's return on equity?
Merit Medical Systems (MMSI) reported return on equity of 9.1% in Q1 2026.
How has Merit Medical Systems's return on equity changed year-over-year?
Merit Medical Systems's return on equity decreased by 0.5% year-over-year, from 9.2% to 9.1%.
What is the long-term trend for Merit Medical Systems's return on equity?
Over 5 years (2020 to 2025), Merit Medical Systems's return on equity has grown at a 53.1% compound annual growth rate (CAGR), from -1% to 8.7%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.